(Q44675066)

5 December 2017

PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity (English)

1 reference

5 December 2017

0 references

1 reference

Jessal J Patel

1

1 reference

PubMed ID

24615887

5 December 2017

Oliver R Butters

series ordinal

2

1 reference

PubMed ID

24615887

5 December 2017

Timothy R Arnett

series ordinal

3

1 reference

5 December 2017

24 February 2014

1 reference

Cell Biochemistry & Function

5 December 2017

1 reference

5 December 2017

32

1 reference

5 December 2017

4

1 reference

5 December 2017

368-377

1 reference

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

5 December 2017

1 reference

Recent UK trends in the unequal burden of coronary heart disease

21 January 2018

1 reference

Global estimates of the prevalence of diabetes for 2010 and 2030

21 January 2018

1 reference

Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association

21 January 2018

1 reference

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

21 January 2018

1 reference

Use of thiazolidinediones and fracture risk

21 January 2018

1 reference

A cohort study of thiazolidinediones and fractures in older adults with diabetes

21 January 2018

1 reference

Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes

21 January 2018

1 reference

Forming functional fat: a growing understanding of adipocyte differentiation

21 January 2018

1 reference

21 January 2018

1 reference

PPARs in bone: the role in bone cell differentiation and regulation of energy metabolism

21 January 2018

1 reference

Transcription factors controlling osteoblastogenesis

21 January 2018

1 reference

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

The mode of action of thiazolidinediones

21 January 2018

1 reference

Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation

21 January 2018

1 reference

Bone is a target for the antidiabetic compound rosiglitazone.

21 January 2018

1 reference

PPAR-gamma regulates osteoclastogenesis in mice

21 January 2018

1 reference

A novel PPARgamma agonist, KR62776, suppresses RANKL-induced osteoclast differentiation and activity by inhibiting MAP kinase pathways

21 January 2018

1 reference

Thiazolidinediones inhibit TNF-alpha-mediated osteoclast differentiation of RAW264.7 macrophages and mouse bone marrow cells through downregulation of NFATc1.

21 January 2018

1 reference

Fibrates, glitazones, and peroxisome proliferator-activated receptors

21 January 2018

1 reference

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.

21 January 2018

1 reference

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)alpha agonist fenofibrate and the PPARgamma agonist pioglitazone

21 January 2018

1 reference

HMG-CoA reductase inhibitors and the risk of fractures

21 January 2018

1 reference

The peroxisome proliferator activator receptor alpha/delta agonists linoleic acid and bezafibrate upregulate osteoblast differentiation and induce periosteal bone formation in vivo.

21 January 2018

1 reference

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase-Dependent Regulation of the Orphan Nuclear Receptor SHP

21 January 2018

1 reference

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies.

21 January 2018

1 reference

AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass

21 January 2018

1 reference

The effect of metformin on alveolar bone in ligature-induced periodontitis in rats: a pilot study

21 January 2018

1 reference

AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts

21 January 2018

1 reference

Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats.

21 January 2018

1 reference

Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes

21 January 2018

1 reference

The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing.

21 January 2018

1 reference

Hypothermia inhibits osteoblast differentiation and bone formation but stimulates osteoclastogenesis.

21 January 2018

1 reference

21 January 2018

Rat osteoblast cultures

1 reference

Hypoxia stimulates vesicular ATP release from rat osteoblasts.

21 January 2018

1 reference

Rodent osteoclast cultures.

21 January 2018

1 reference

The PPARs: from orphan receptors to drug discovery

21 January 2018

1 reference

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats

21 January 2018

1 reference

Diabetes and fragility fractures - a burgeoning epidemic?

21 January 2018

1 reference

High serum total cholesterol is a long-term cause of osteoporotic fracture

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/CBF.3025

1 reference

5 December 2017

1 reference

PubMed ID

24615887